Berry Genomics Co.,Ltd (SHE:000710)
China · Delayed Price · Currency is CNY 14.68
+0.04 (0.27%)
Aug 1, 2025, 3:05 PM CST
SolarWinds Market Cap
Berry Genomics Co.,Ltd has a market cap or net worth of 5.19 billion as of August 1, 2025. Its market cap has increased by 99.19% in one year.
Market Cap
5.19B
Enterprise Value
5.13B
Revenue
1.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
$14.68
Market Cap Chart
Since June 20, 2017, Berry Genomics Co.,Ltd's market cap has decreased from 24.43B to 5.19B, a decrease of -78.75%. That is a compound annual growth rate of -17.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 5.19B | 73.73% |
| Dec 31, 2024 | 2.99B | -26.65% |
| Dec 29, 2023 | 4.07B | 0.96% |
| Dec 30, 2022 | 4.03B | -40.71% |
| Dec 31, 2021 | 6.80B | -49.03% |
| Dec 31, 2020 | 13.35B | 2.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 424.11B |
| Shenzhen Mindray Bio-Medical Electronics | 287.79B |
| WuXi AppTec | 282.67B |
| Sichuan Biokin Pharmaceutical | 130.49B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.06B |
| Aier Eye Hospital Group | 122.33B |
| Shanghai United Imaging Healthcare | 112.35B |
| Yunnan Baiyao Group Co.,Ltd | 102.45B |